Search
![](https://static.wixstatic.com/media/nsplsh_4539556366656b2d4c7030~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_4539556366656b2d4c7030~mv2.jpg)
![USFDA Guidance: Covariates RCT, Non-Clinical Performance Assessment of Tissue & Efficacy Endpoints](https://static.wixstatic.com/media/nsplsh_4539556366656b2d4c7030~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_4539556366656b2d4c7030~mv2.jpg)
Sharan Murugan
- May 25, 2023
- 2 min
USFDA Guidance: Covariates RCT, Non-Clinical Performance Assessment of Tissue & Efficacy Endpoints
Today (26 May 2023) the United States Food & Drug Administration released multiple guidances related to both drugs/biologics and medical...
12 views0 comments
![](https://static.wixstatic.com/media/nsplsh_725c521c6f83473db0f4913eba204f0d~mv2.jpg/v1/fill/w_250,h_250,fp_0.50_0.50,q_30,blur_30,enc_auto/nsplsh_725c521c6f83473db0f4913eba204f0d~mv2.jpg)
![USFDA Guidance: Multiple Endpoints in Clinical Trials & Gene Therapy for Neurodegenerative Diseases](https://static.wixstatic.com/media/nsplsh_725c521c6f83473db0f4913eba204f0d~mv2.jpg/v1/fill/w_399,h_300,fp_0.50_0.50,q_90,enc_auto/nsplsh_725c521c6f83473db0f4913eba204f0d~mv2.jpg)
Sharan Murugan
- Oct 23, 2022
- 1 min
USFDA Guidance: Multiple Endpoints in Clinical Trials & Gene Therapy for Neurodegenerative Diseases
Earlier on 21 October 2022, the USFDA released two finalized guidances "Multiple Endpoints in Clinical Trials" and "Human Gene Therapy...
12 views0 comments